Philipp K.
- Country
- Germany
- Department
- #40073; Rheumatologie
Research Overview
- Efficacy and Safety Evaluation of Bimekizumab Versus Risankizumab in Adults with Active Psoriatic Arthritis: A Multicenter, Randomized, Double-Blind Study
- Efficacy and Safety of Secukinumab in Delaying Relapse in New-Onset Giant Cell Arteritis Patients in Clinical Remission
- Efficacy and Safety of Subcutaneous Anifrolumab Versus Placebo in Adult Idiopathic Inflammatory Myopathies: A Phase III, Double-Blind, Multicenter Study
Data & Insights
Has run more than one trial at 19 of 143 partner sites.
Specializations
Rheumatology
Conducts research in psoriatic arthritis treatment, investigating novel therapeutic approaches for patients with active disease conditions. The investigator has expertise in evaluating comparative treatment efficacy in inflammatory joint disorders.
- Psoriatic Arthritis Management
- Inflammatory Joint Disease
Focuses on assessment of therapeutic responses in chronic inflammatory conditions affecting joints and skin.
Autoimmune Disorders
Specializes in treating idiopathic inflammatory myopathies, particularly polymyositis and dermatomyositis. The investigator evaluates advanced therapeutic interventions for these rare inflammatory muscle conditions.
- Inflammatory Muscle Diseases
- Autoimmune Disease Management
Evaluates disease activity patterns and therapeutic responses in inflammatory muscle disorders.
Vascular Medicine
Focuses on the treatment of giant cell arteritis, investigating innovative approaches for maintaining disease remission. The investigator studies therapeutic strategies in vasculitis management.
- Vasculitis Treatment
- Inflammatory Vascular Disease
Explores treatment options for vascular inflammatory conditions with emphasis on long-term disease control.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.